Philadelphia, PA – June 9, 2009 – Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today announced the appointment of Terence D. Vollrath as executive vice president of its wholly owned subsidiary, Cody Laboratories (Cody), a manufacturer/supplier of bulk active pharmaceutical ingredients (API).

Vollrath, 52, reports to Richard Asherman, chief executive officer of Cody.

“Terry brings more than 20 years of operations, process development and business development experience in the API field,” said Arthur Bedrosian, president and chief executive officer of Lannett. “We look forward to benefiting from his expertise and insights, gained from working with big pharma as well as chemical and biotech firms, as we build our pain management business.”

Vollrath most recently served as vice president operations for Minrad International, Inc. Earlier, he provided consulting services to the pharmaceutical chemicals, biotech and pharmaceutical industries, and before that served as director of operations for Aerojet Fine Chemicals. From 1978 to 1997, Vollrath rose through the management ranks of Abbott Laboratories. Vollrath earned a bachelor of science degree in chemical engineering from the University of Wisconsin and a master of business administration degree from Lake Forest Graduate School of Management.

Lannett Company:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. For more information, visit Lannett Company’s website at www.lannett.com.